Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 31 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 11033588

    Compositions for treating inflammation and uses thereof

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  2. US 11033584

    Targeted replacement of endogenous T cell receptors

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  3. US 11033605

    Methods of promoting angiogenesis in tissue with fibromodulin

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  4. US 11034933

    Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  5. US 11028412

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  6. US 11028362

    Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  7. US 11028128

    Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  8. US 11028129

    Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  9. US 11028162

    Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  10. US 11021517

    Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  11. US 11021523

    Cyanobacteriochromes active in the far-red to near-infrared

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  12. US 11021506

    Thiosaccharide mucolytic agents

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  13. US 11021497

    Compositions and methods for synthesis of phosphorylated molecules

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  14. US 11020488

    Pyrroloquinolin compounds and methods of using same

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  15. US 11020463

    Method of determining cellular protein homeostasis

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  16. US 11020409

    Broad antiviral therapy with membrane modifying oxysterols

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  17. US 11020345

    Nanostraw devices and methods of fabricating and using the same

    The Regents of the University of California The Board of Trustees of the Leland Stanford Junior University Stanford · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  18. US 11021545

    Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  19. US 11016093

    Disease-associated antigens and methods of use thereof

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  20. US 11014980

    Transforming growth factor-beta-responsive polypeptides and their methods for use

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  21. US 11014950

    Nucleotide analogs

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  22. US 11013705

    Methods and compositions for supporting renal health

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  23. US 11014955

    Cyclic peroxides as prodrugs for selective delivery of agents

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  24. US 11008381

    Antibodies to oxidized phospholipids

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted